Skip to main content
Clinical Trials/NCT06584981
NCT06584981CompletedNot Applicable

Effect of PECS II, Parasternal and Serratus Plane Blocks on Postoperative Pain in MIDCAB Surgery

Hisar Intercontinental Hospital1 site in 1 country88 target enrollmentStarted: September 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
88
Locations
1
Primary Endpoint
Analgesic efficiency

Study Overview

Brief Summary

AIM: It was aimed to evaluate the effectiveness of pectoral nerve block (PECS II), parasternal and serratus plane blocks in postoperative analgesia in minimally invasive cardiac surgery (MIDCAB).

INTRODUCTION: The frequency of minimally invasive cardiac surgery has increased in recent years. With this method, Coronary artery bypass graft (CABG) operations can be performed without sternotomy. It is a beneficial method for early postoperative mobilization, early recovery and better aesthetic appearance. Since there is a surgical intervention between the ribs, pain control is important in these patients.

METHOD: In the preoperative evaluation of patients planned for CABG, PECS II, parasternal and serratus plane blocks are routinely recommended for postoperative pain control. Consent for the procedure is obtained from patients who accept this procedure. After induction and before the surgical incision, these block applications are performed under sterile conditions under the guidance of ultrasonography. Standard intravenous analgesic agents are applied to our patients who do not accept block applications. The hospital core system files of our patients who underwent cardiac surgery with minimally invasive intervention in our hospital between January 1, 2021 and December 31, 2021 will be scanned retrospectively. Patients with and without block application will be divided into two groups. From our patients' files; Demographic data, extubation time, drain site and incision site pain at the 1st, 2nd, 4th, 12th, 24th, 48th and 72nd hours after extubation will be noted. In addition, it will be noted whether there is a need for additional rescue analgesia in cases where block is performed. The data obtained will be evaluated statistically and the results will be published in national or international scientific journals.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Crossover
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients aged 18 and over
  • •Patients who underwent MIDCAB surgery

Exclusion Criteria

  • •Patients under 18 years of age
  • •Patients who did not undergo MIDCAB surgery

Arms & Interventions

Patients who underwent block

Active Comparator

Patients who underwent pectoral nerve block (PECS II), parasternal and serratus plane blocks will be included in this group.

Intervention: pectoral nerve block (PECS II), parasternal and serratus plane blocks (Procedure)

Patients who did not receive block

Other

Patients who were not given a block and received standard intravenous analgesics will be included in this group.

Intervention: analgesic (Other)

Outcomes

Primary Outcomes

Analgesic efficiency

Time Frame: drain site and incision site pain at the 1st, 2nd, 4th, 12th, 24th, 48th and 72nd hours after extubation will be noted

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hasan Hüseyin KILIÇ

Hasan Huseyin Kilic

Hisar Intercontinental Hospital

Study Sites (1)

Loading locations...

Similar Trials